Prognostic Value of Bladder Involvement in the Outcome of Upper Tract Urothelial Carcinoma
Authors:
- Sara MeirelesSMSara Meireles
- Nuno DiasNDNuno Dias
- Diana MartinsDMDiana Martins
- Carolina DiasCDCarolina Dias
- Marina GonçalvesMGMarina Gonçalves
- João SilvaJSJoão Silva
- Carlos Martins SilvaCSCarlos Martins Silva
- Paulo Dinis OliveiraPOPaulo Dinis Oliveira
- Paula SoaresPaula Soares
- José Manuel LopesJosé Manuel Lopes
Open Access
- 2 January 2023
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 13 (1) , 153
Abstract
Accurately predicting the clinical prognosis of upper tract urothelial carcinoma (UTUC) seems crucial. We evaluated the effect of the involvement of urothelial bladder carcinoma (UBC) as a potential prognostic factor for overall survival (OS) and progression-free survival (PFS). The cohort included 115 patients with UTUC, subgrouped between January 2009 and December 2019 as follows: (1) only UTUC and (2) UTUC with synchronous or metachronous UBC (UTUC + UBC). Univariate and multivariate analyses were performed to identify independent prognostic factors for OS and PFS. Synchronous or metachronous UBC diagnosis in UTUC patients was an independent predictor of worse PFS (HR 3.326 CI 95% 1.474–7.503, p = 0.004), but it was not identified as a prognostic factor for OS (p > 0.05). Lymphovascular invasion (LVI) was associated with decreased PFS (HR 2.687 CI 95%1.172–6.163, p = 0.020) and OS (HR 4.980 CI 95%1.763–14.064, p = 0.002). This study indicates that concomitant or later UBC could predict a poor PFS, but it is not associated with a significantly worse OS in UTUC patients. The prognostic impact of LVI underlines its inclusion in the tumor staging system of UTUC.Keywords
Funding Information
- Norte Portugal Regional Operational Programme (NORTE 2020) (NORTE-01-0145-FEDER-000051, NORTE-01-0145-FEDER-072678)
- European Regional Development Fund (ERDF) (NORTE-01-0145-FEDER-000051, NORTE-01-0145-FEDER-072678)
This publication has 33 references indexed in Scilit:
- Comparison of the clonality of urothelial carcinoma developing in the upper urinary tract and those developing in the bladderSpringerPlus, 2013
- Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973–2005BJU International, 2010
- Lymphovascular Invasion Predicts Clinical Outcomes in Patients With Node-Negative Upper Tract Urothelial CarcinomaJournal of Clinical Oncology, 2009
- Independent predictors of cancer‐specific survival in transitional cell carcinoma of the upper urinary tractCancer, 2007
- BLADDER CANCER AS A PROGNOSTIC FACTOR FOR UPPER TRACT TRANSITIONAL CELL CARCINOMAJournal of Urology, 2004
- MULTIFOCAL TRANSITIONAL CELL CARCINOMA OF THE BLADDER AND UPPER URINARY TRACT: MOLECULAR SCREENING OF CLONAL ORIGIN BY CHARACTERIZING CD44 ALTERNATIVE SPLICING PATTERNSJournal of Urology, 2004
- Clonality of multifocal urothelial carcinomas: 10 years of molecular genetic studiesInternational Journal of Cancer, 2002
- Evidence for oligoclonality and tumor spread by intraluminal seeding in multifocal urothelial carcinomas of the upper and lower urinary tractOncogene, 2001
- Metachronous multifocal development of urothelial cancers by intraluminal seedingThe Lancet, 1993
- Bladder Cancer — Field versus Clonal OriginNew England Journal of Medicine, 1992